Slingshot members are tracking this event:
Phase 3 overall survival data of CPX-351 for Secondary AML due 1Q 2016
Slingshot Insights Explained
Mar 14, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Secondary Aml, Phase 3, Cpx-351, Vyxeos, Combiplex, Aacr-nci-eortc